This is reported by the local newspaper Financial Times.

It is noteworthy that the chip is built into the existing Abilify drug produced by the Japanese company Otsuka, which is used to treat psychoses.

When swallowing the tablet, the chip will send information to the patient's mobile device and automatically forward it to the treating doctor, thereby avoiding a situation where patients do not follow the prescribed mode of taking the medicine.

Non-compliance with prescriptions of doctors is one of the most urgent problems of modern medicine.

As the head of the North American division of Otsuka Kabin Nath said, the innovation tool will be produced in limited quantities to determine demand.

At the same time he refused to disclose the details as to how much the drug with the chip will be more expensive than the usual medicine.

As previously reported in URA-Inform, the Ministry of Health advocates the purchase of medicines directly from their producers. According to the ministry, public procurement should be carried out directly from manufacturers of medicines.